Practical Opportunities in AMD Management

Sponsored by MacuLogix
Although AMD is a devastating disease, this report is saturated with hope and backed by the promise of clear, published scientific evidence. Indeed, we have come a long way in four years. The path forward is bright, heavily traveled and undeniably in the best interests of our patients and our practices.